Skip to contents

  1. Schreibmayer, Peter [Author] ; Technische Universität Graz Institut für Architekturtechnologie

    One2one : minimal space, minimal housing

    Books
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Graz: Verl. der Techn. Univ. Graz, 2009

  2. Kammerer, Sarah; Jahn, Stephan Wenzel; Winter, Elke; Eidenhammer, Sylvia; Rezania, Simin; Regitnig, Peter; Pichler, Martin; Schreibmayer, Wolfgang; Bauernhofer, Thomas

    Critical evaluation ofKCNJ3gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    BMJ, 2016

    Published in: Journal of Clinical Pathology

  3. Wagner, Valerie; Stadelmeyer, Elke; Riederer, Monika; Regitnig, Peter; Gorischek, Astrid; DeVaney, Trevor; Schmidt, Kurt; Tritthart, Helmut A.; Hirschberg, Koret; Bauernhofer, Thomas; Schreibmayer, Wolfgang

    Cloning and characterisation of GIRK1 variants resulting from alternative RNA editing of the KCNJ3 gene transcript in a human breast cancer cell line

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Wiley, 2010

    Published in: Journal of Cellular Biochemistry

  4. Kammerer, Sarah; Sokolowski, Armin; Hackl, Hubert; Platzer, Dieter; Jahn, Stephan Wenzel; El-Heliebi, Amin; Schwarzenbacher, Daniela; Stiegelbauer, Verena; Pichler, Martin; Rezania, Simin; Fiegl, Heidelinde; Peintinger, Florentia; Regitnig, Peter; Hoefler, Gerald; Schreibmayer, Wolfgang; Bauernhofer, Thomas

    KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Impact Journals, LLC, 2016

    Published in: Oncotarget